On Wednesday, Parker-Hannifin Corp(NYSE:PH)’s shares declined -1.08% to $100.59.
Parker Hannifin Corporation (PH), the global leader in motion and control technologies, recently unveiled a new version of its Win StrategyTM at an investor meeting in New York. The Win Strategy is the Parker business system and was originally introduced in 2001. It has been instrumental in transforming the company`s operations and optimizing performance.
Presentations at the meeting by Tom Williams, Chief Executive Officer; Lee Banks, President and Chief Operating Officer; Jon Marten, Executive Vice President - Finance and Administration and Chief Financial Officer; and Bob Bond, Corporate Vice President, e-Business, IoT, Services, laid out the details of the strategy during the half-day meeting. While many of the core principles of the strategy will remain in place, new strategies are being implemented to improve speed and performance. Key aims under the new strategy comprise:
- Engaged People - high engagement and ownership by Parker team members drives exceptional performance.
- Premier Customer Experience - moving from a service mindset to creating a great customer experience enables growth.
- Profitable Growth - implement strategies to grow organically 150 basis points faster than the market.
Parker-Hannifin Corporation manufactures and sells motion and control technologies and systems for various mobile, industrial, and aerospace markets worldwide. The company operates in two segments, Diversified Industrial and Aerospace Systems.
Geron Corporation(NASDAQ:GERN)’s shares gained 2.47% to $3.32.
Geron Corporation (GERN) stated financial results for the second quarter ended June 30, 2015.
Second Quarter 2015 Results
For the second quarter of 2015, the company stated a net loss of $9.4 million, or $0.06 per share, contrast to $8.7 million, or $0.06 per share, for the comparable 2014 period. Revenues for the second quarter of 2015 were $251,000 contrast to $341,000 for the comparable 2014 period. Interest and other income for the second quarter of 2015 amounted to $145,000 contrast to $99,000 for the comparable 2014 period. The company ended the second quarter of 2015 with $157.0 million in cash and investments.
Total operating expenses for the second quarter of 2015 were $9.7 million contrast to $9.0 million for the comparable 2014 period. Research and development expenses for the second quarter of 2015 were $4.8 million contrast to $5.2 million for the comparable 2014 period. General and administrative expenses for the second quarter of 2015 were $4.0 million contrast to $3.9 million for the comparable 2014 period. Operating expenses for the 2015 second quarter also comprised of restructuring charges of $941,000 in connection with the company’s organizational resizing declared in March 2015.
Geron Corporation, a clinical stage biopharmaceutical company, focuses on the development of telomerase inhibitor, imetelstat, for treating hematologic myeloid malignancies. It has partnership and license agreement with Janssen Biotech, Inc. to develop and commercialize imetelstat worldwide for indications in oncology, counting hematologic myeloid malignancies and other human therapeutic uses. The company was founded in 1990 and is based in Menlo Park, California.
At the end of Wednesday’s trade, Flowserve Corp(NYSE:FLS)‘s shares dipped -1.36% to $40.82.
Flowserve Corporation, (FLS), a leading provider of flow control products and services for the global infrastructure markets, declared that its Board of Directors has authorized a quarterly cash dividend of $0.18 per share on the company`s outstanding shares of common stock. The dividend is payable on October 9, 2015, to shareholders of record as of the close of business on September 25, 2015. While Flowserve presently intends to pay regular quarterly cash dividends for the foreseeable future, any future dividends, at this $0.18 per share rate or otherwise, will be reviewed individually and declared by the Board at its discretion, dependent on the Board`s assessment of the company`s financial condition and business outlook at the applicable time.
Flowserve Corporation designs, manufactures, distributes, and services industrial flow administration equipment worldwide. The company operates through three segments: Engineered Product Division (EPD), Industrial Product Division (IPD), and Flow Control Division (FCD). The EPD segment offers custom and other engineered pumps and pump systems, mechanical seals, auxiliary systems, replacement parts, and related equipment and services, in addition to manufactures gas-lubricated mechanical seals used in high-speed compressors.
Gap Inc(NYSE:GPS), ended its Wednesday’s trading session with -1.33% loss, and closed at $31.27.
Gap is happy to release its fourth exclusive menswear collection designed by GQ’s four Best New Menswear Designers in America for 2015. Following three previous seasons’ successful collaborations, this year’s collection highlights each designer’s perspective on classic menswear pieces.
The collection comprises tailored blazers and trousers, overcoats, leather jackets, graphic and classic tees, sweatshirts, sweatpants, denim, and field jackets, together with accessories — counting shoes, hats, bags, socks, and ties. The collection is accessible starting September 29th, at select Gap stores in more than seven countries, counting the USA, Canada, China, Hong Kong, Japan, and throughout Europe. It will also be accessible online at www.gap.com with prices ranging from $14 to $460.
The Gap, Inc. operates as an apparel retail company worldwide. It offers apparel, accessories, and personal care products for men, women, and children under the Gap, Banana Republic, Old Navy, Athleta, and Intermix brand names. The company provides apparel, handbags, shoes, jewelry, personal care products, and eyewear for men and women; and performance and lifestyle apparel for use in yoga, strength training, and running, in addition to seasonal sports, counting skiing and tennis.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
